Research & Development

一本道久久久999欧美最大色情网183亚洲成人视频吉利GE11最新消息 将于2月26日亮相


  大長秋哈哈哈大笑道︰“貴人怎麼起了這樣奇怪的心思?區區幾條魚罷了。”一本道久久久999   雲瑯剝開一顆松子丟嘴里道︰“先用清水泡,然後加調料大火煮,然後風干,最後加沙子炒就能吃到開口松子了。”欧美最大色情网183   “廢話,當然是真的,你以為什麼都不懂的阿喬能撐起莊子?這個莊子可不是我一個人的,大家人人有份。”   甦稚一下子就跳起來,連忙問道︰“我是軍醫!”亚洲成人视频   “要不,找找郭大俠,請他幫我們說項說項,長門宮如果也賣煤,我們就只能吃煤了……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo